- $37.95m
- $63.20m
- $53.11m
- 25
- 48
- 54
- 38
2020 December 31st | 2021 December 31st | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 43.7 | 53.1 |
Cost of Revenue | ||||
Gross Profit | — | — | 30.1 | 39.7 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | — | 2 | 90.9 | 110 |
Operating Profit | 0 | -2 | -47.2 | -56.6 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | — | 1.88 | -47.4 | -51.8 |
Provision for Income Taxes | ||||
Net Income After Taxes | — | 1.88 | -47.5 | -51.9 |
Net Income Before Extraordinary Items | ||||
Net Income | — | 1.88 | -47.5 | -51.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | 1.88 | -47.5 | -51.9 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | 0.057 | -0.782 | -0.819 |